Skip to main content

Verdezyne Wins $1.7M STTR Grant

NEW YORK (GenomeWeb News) – Verdezyne has received a $1.7 million grant from the National Institute of Allergy and Infectious Diseases that it will use to develop gene libraries for synthetic biology applications in its fermentation development program, the company said today.

The company, which formerly went by the name Coda Genomics, will use the Small Business Technology Transfer grant to fund development of bioinformatics applications for use in its mutant library and synthetic biology programs.

"By advancing this technology, we will be able to utilize the computational tools for improved protein expression and function for our internal biofuel and bio-based chemical programs," Verdezyne Chief Scientific Officer Stephen Picataggio said in a statement.

The firm said that the gene libraries platform it is developing will enhance current metabolic engineering tools.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.